Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Can J Anaesth ; 51(2): 139-44, 2004 Feb.
Article in English | MEDLINE | ID: mdl-14766690

ABSTRACT

PURPOSE: Describe the diagnosis, clinical features, pathophysiology, treatment and anesthetic management of amniotic fluid embolism (AFE) in a patient undergoing second trimester pregnancy termination. CLINICAL FEATURES: A 30-yr-old gravida 2, para 1, woman was admitted for a dilatation and evacuation procedure for underlying intra-uterine fetal demise in her second trimester of pregnancy. Hypotension, shock, respiratory arrest, pulseless electrical activity, hemorrhage, disseminated intravascular coagulopathy, requiring cardiopulmonary resuscitation and blood transfusion complicated her intraoperative care. AFE was considered the most likely cause of this intraoperative event. CONCLUSIONS: It is now recognized that the pathophysiological features of AFE are similar to a type-1 hypersensitivity reaction ranging from mild systemic reaction to anaphylaxis and shock. AFE has a high maternal and fetal morbidity and mortality rate, requiring prompt recognition and treatment. In patients with cardiovascular instability, the treatment of AFE is similar to anaphylaxis requiring aggressive fluid hydration, cardiopulmonary resuscitation, administration of blood products and the use of vasopressors.


Subject(s)
Dilatation and Curettage/adverse effects , Embolism, Amniotic Fluid/diagnosis , Embolism, Amniotic Fluid/therapy , Fetal Death/surgery , Adult , Anesthesia, Obstetrical/methods , Anesthetics, Intravenous/therapeutic use , Anesthetics, Local/therapeutic use , Cardiopulmonary Resuscitation , Embolism, Amniotic Fluid/blood , Embolism, Amniotic Fluid/physiopathology , Female , Fentanyl/therapeutic use , Hemodynamics/physiology , Humans , Intubation, Intratracheal , Mepivacaine/therapeutic use , Midazolam/therapeutic use , Monitoring, Intraoperative , Oxygen/therapeutic use , Pregnancy , Pregnancy Trimester, Second/blood , Propofol/therapeutic use , Vasoconstrictor Agents/therapeutic use , Vasopressins/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...